Nashville-based Claritas Health Ventures announced today the completion of a Series B investment into MyWoundDoctor, an innovative provider of virtual tech-enabled wound care services offered through a patent-pending AI-based process.
NASHVILLE, TN, September 24, 2021 /24-7PressRelease/ — The U.S. healthcare system spends more than $60 billion per year on wound care as it treats more than 8 million patients. MyWoundDoctor addresses rising cost, quality issues, and accessibility by providing caregivers and patients with evidence-based remote wound care treatment and personalized supplies initiated through an easy-to-use telehealth mobile imaging application. The wound industry is large and growing, yet there is a shortage of certified wound clinicians and nurses to treat patients. Through a remote platform that utilizes top-notch technology, MyWoundDoctor allows more people in rural, urban, and all over the country, to receive high-quality wound care. The Claritas investment will enable MyWoundDoctor to scale its business, expand into new markets such as Home Health Care, Skilled & Long-Term Care Nursing Facilities, Rehabilitation Facilities, Hospice/Palliative Care, Rural Hospitals and Urgent Care organizations.
“Wound care is a significant cost and quality issue within the American healthcare system,” said Dan Heneghan, chief executive officer, MyWoundDoctor. “This investment from Claritas will help us scale our operations so that we can deliver expertise directly to patients anywhere, reducing their wound care costs as we improve both outcomes and quality of life.”
“Virtual care is modernizing and expanding access to care for patients, and MyWoundDoctor’s top-notch remote wound care specialists streamline the process and deliver highly effective, affordable, and convenient wound care,” said Tania Grant, Principal, Claritas Health Ventures. “We are excited to partner with MyWoundDoctor to ensure that every patient receives the effective wound care that they need to heal.”
MyWoundDoctor provides the healthcare industry with an innovative, telehealth-enabled wound care service through its patent-pending, AI-based process. Founded in 2016 by board-certified, Stanford-trained Nick Sieveking, MD, CWSP, a Nashville-based plastic surgeon and wound care expert, MyWoundDoctor integrates wound imaging technology, proprietary clinical protocols, and a wound care supply selection and delivery process that reduces care costs, increases patient satisfaction, and supports effective wound healing.
MyWoundDoctor offers patients, caregivers, and clinicians a secure, personalized approach to expert wound care, helping manage any wound care need by convenient access to certified wound care physicians and nurses, and concise wound care training videos. Through its convenient, effective, and innovative wound care service, MyWoundDoctor improves the quality of life for both patients and their caregivers.
To learn more visit www.mywounddoctor.com for more information.
About Claritas Health Ventures
Claritas Health Ventures is the dedicated healthcare investing arm of Claritas Capital, a private equity firm with two decades of experience investing in emerging, lower middle market transformative healthcare companies. Claritas seeks management teams building companies with a mission to drive access, equity, reduced costs, and improved outcomes in healthcare, and partners as lead minority investors providing up to $25 million of capital to accelerate growth. Investments include digital health, femtech, mental health, health equity, data services, provider services, population marketplaces, and software solutions. Claritas Health Ventures is based in Nashville, Tennessee.
To learn more about Claritas Health Ventures, visit claritashealthventures.com
For the original version of this press release, please visit 24-7PressRelease.com here